Unity Biotechnology (STU:9U90) Total Assets : €54.15 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Total Assets?

Unity Biotechnology's Total Assets for the quarter that ended in Mar. 2024 was €54.15 Mil.

During the past 12 months, Unity Biotechnology's average Total Assets Growth Rate was -27.00% per year. During the past 3 years, the average Total Assets Growth Rate was -27.30% per year. During the past 5 years, the average Total Assets Growth Rate was 12.50% per year.

During the past 8 years, Unity Biotechnology's highest 3-Year average Total Assets Growth Rate was 55.80%. The lowest was -27.30%. And the median was 47.70%.

Total Assets is connected with ROA %. Unity Biotechnology's annualized ROA % for the quarter that ended in Mar. 2024 was -37.25%. Total Assets is also linked to Revenue through Asset Turnover. Unity Biotechnology's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

Unity Biotechnology Total Assets Historical Data

The historical data trend for Unity Biotechnology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Total Assets Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

136.10

128.49

110.37

117.39

60.24

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															106.71	93.23	64.91	60.24	54.15

Unity Biotechnology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Unity Biotechnology's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	26.041	+	34.197
	=	60.24

Unity Biotechnology's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	22.069	+	32.085
	=	54.15

Unity Biotechnology (STU:9U90) Total Assets Explanation

Total Assets is connected with ROA %.

Unity Biotechnology's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-21.308	/	( (60.238	+	54.154)	/ 2 )
	=	-21.308	/	57.196
	=	-37.25 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Unity Biotechnology's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0	/	( (60.238	+	54.154)	/ 2 )
=	0	/	57.196
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Unity Biotechnology Total Assets Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines